Shares of Incyte Corp. INCY advanced 2.14% to $85.11 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.08% to 4,226.52 and Dow Jones Industrial Average DJIA falling 0.36% to 34,630.24. This was the stock's third consecutive day of gains. Incyte Corp. closed $25.26 short of its 52-week high ($110.37), which the company achieved on July 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Pfizer Inc. PFE fell 0.41% to $38.99, Novartis AG ADR NVS fell 0.14% to $89.67, and Eli Lilly & Co. LLY rose 10.15% to $222.52. Trading volume (1.2 M) eclipsed its 50-day average volume of 1.1 M.